Skip to main content
OpenTrials
Completed

NCT Number: NCT05370859

mMe: Motivational Monitoring to Enhance Smoking Cessation Among Cancer Patients

The objectives of this study are to pilot test a protocol of weekly assessments of motivation to quit and other relevant constructs combined with information about how to enroll in cessation programs, which will allow initial quantification of motivation to quit during cancer treatment and develop hypotheses about the impact of motivation on the decision to enroll in services.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University of Virginia Cancer Center and affiliated sites

Charlottesville, Virginia, 22908, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • An adult (18+)
  • Current smoker defined by: Has smoked 100 cigarettes in their lifetime (may be multi-tobacco users as long as they also use combustible cigarettes).
  • Any type of cancer (except non-melanoma skin cancer)
  • Anticipates receiving any of the following cancer treatments in the 3 months following enrollment: chemotherapy, surgery, immunotherapy, bone marrow or stem cell transplant, hormone therapy, or radiation
  • Access to the Internet

Exclusion criteria

  • Not smoked 100 cigarettes in their lifetime
  • < 18 years in age
  • Diagnosed with non-melanoma skin cancer
  • Not diagnosed with cancer
  • Does not anticipate receiving cancer treatments in the 3 months following enrollment
  • Has been previously enrolled in an existing Cancer Center Tobacco Treatment Program (TTP)
  • Not comfortable reading and responding to questions in English
  • No consistent access to the Internet

Treatment and study plan

There is no intervention for this study

Other

There is no intervention or exposure for this study

Primary outcomes

  1. Number of participants who enroll in cessation services

    Time frame: 12 weeks after study start

    Assessed using administrative records

Secondary outcomes

  1. Level of and change in motivation and self-efficacy to quit smoking

    Time frame: Through study completion, an average of 12 weeks

    Assessed using self-report on the weekly and 12-week survey

  2. Level of and change in anxiety and depression

    Time frame: Through study completion, an average of 12 weeks

    Assessed using self-report (PHQ-4) on the weekly and 12-week survey

  3. Number of smoking quit attempts

    Time frame: 12 weeks after study start

    Assessed using self-report on the weekly and 12-week survey

Sponsors and collaborators

Lead sponsor

University of Virginia

Other

Registry information

Official study title

Motivational Monitoring to Enhance Smoking Cessation Among Cancer Patients Pilot Study

Acronym: mMe

Important dates

Study start
2022
Primary completion
2024
Study completion
2024
First posted
May 12, 2022
Registry last updated
Apr 3, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.